| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8784862 | Advances in Radiation Oncology | 2018 | 21 Pages |
Abstract
In this prospective evaluation, postresection CA19-9 was a significant predictor of both LRR and DF, whereas SMS was not. These findings support consideration of adjuvant radiation therapy dose intensification in patients with elevated postresection CA19-9.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
William F. MD, Kathryn MS, Ross A. MD, Howard MD, Ivan L. MD, Yuhchyau MD, PhD, James A. MD, Eric D. MD, Thomas A. MD, Samir MD, John P. MD, Rakesh MD, Guila MD, John H. MD, Joshua E. MD, Michael G. MD, Mukund S. MD, Gilbert D.A. MD, Christopher H. MD,